Hydrogenetics, Inc.
HYGN
$0.0001
$0.000.00%
| 09/30/2009 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -- | ||||
| SG&A Expenses | 59.70% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 59.49% | ||||
| Operating Income | -59.49% | ||||
| Income Before Tax | -329.26% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -329.26% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -329.26% | ||||
| EBIT | -59.49% | ||||
| EBITDA | -59.70% | ||||
| EPS Basic | -300.00% | ||||
| Normalized Basic EPS | 0.00% | ||||
| EPS Diluted | -300.00% | ||||
| Normalized Diluted EPS | 0.00% | ||||
| Average Basic Shares Outstanding | 18.57% | ||||
| Average Diluted Shares Outstanding | 18.57% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||
